contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


notice-of-annual-general-meeting-in-windowmaster-international-as-3

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

WindowMaster tilbyder avancerede ventilationsstrategier, der gør det muligt for byggebranchen at reducere sit CO2-aftryk betydeligt. Med målsætningen »At skabe en bedre verden, hvor alle har frisk luft indendørs og et sikkert bygget miljø« udvikler, producerer og distribuerer virksomheden facade- og tagautomatiseringsløsninger til hybridventilation, naturlig ventilation og røgventilationssystemer.

I løbet af de seneste fire år (2020-2024) har WindowMaster leveret en rentabel vækst med en omsætningsvækst på 12 % (CAGR), samtidig med at både EBITDA og cashflow er blevet forbedret. Virksomhedens resultater har vist større modstandsdygtighed end den bredere byggematerialesektor, understøttet af dens eksponering over for det mere stabile renoveringssegment, det stærkt regulerede marked for røgkontrol og voksende investeringer i den grønne omstilling. 
En disciplineret kapitalallokeringsstrategi har skabt betydelig værdi gennem investeringer i innovation, egen produktionskapacitet og den globale salgsorganisation. Disse initiativer har cementeret WindowMasters stærke markedsposition på kernemarkederne i Europa og Nordamerika.

Med en robust platform for både organisk og uorganisk vækst er WindowMaster godt positioneret til at skabe langsigtet værdi for aktionærerne. I 2025 udbetalte virksomheden sit første udbytte siden børsnoteringen, hvilket afspejler dens sunde økonomiske fundament og forpligtelse til at skabe værdi for aktionærerne.


WindowMaster International

Company Announcement No. 072-2026 The Board of Directors is pleased to invite shareholders to the Annual General Meeting of WindowMaster International A/S. The meeting will be held on Thursday...

<div>Company Announcement No. 072-2026</div><div>&nbsp;</div><div>The Board of Directors is pleased to invite shareholders to the Annual General Meeting of WindowMaster International A/S. The meeting will be held on Thursday 9<sup>th</sup> of April 2026 at 3:00 pm (CEST) at Skelstedet 13, 2950&nbsp;Vedbæk.</div><div>&nbsp;</div><div>The notice convening the Annual General Meeting as well as information on how to attend the general meeting are available at:&nbsp;</div><div>&nbsp;</div><div><a href="https://www.windowmaster.dk/om-os/investor/?_gl=1*1am7o7g*_up*MQ..*_ga*MTQ0MzEyODUyLjE3MTEzNjUxODc.*_ga_32KSQ6Z6LS*MTcxMTM2NTE4Ni4xLjAuMTcxMTM2NTE4Ni4wLjAuMA..">Information til investorer (windowmaster.dk)</a></div><div>&nbsp;</div><div>The notice to convene the Annual General Meeting is attached.</div><div>&nbsp;</div><div>The company's 2025 Annual Report will be published on 25<sup>th</sup> March 2026 and presented at the Annual General Meeting on 9<sup>th</sup> April 2026.</div><div>&nbsp;</div><div>&nbsp;</div><div>Vedbæk, March 20th, 2026<br>WindowMaster International A/S</div><div>&nbsp;<br>Lars Fournais, Chairman of the Board &nbsp;<br>Erik Boyter, CEO</div><p><span>&nbsp;</span></p>      <div>        <hr>        <div><strong>Attachments</strong></div>        <div><a href="https://storage.googleapis.com/inderes-widgets-prod-assets/windowmaster/attachments/2e8c6a5f-5630-45dd-99f6-e656a6d120ba/ordinary-call-on-agm-for-wma-2026.pdf">Ordinary call on AGM for WMA 2026.pdf</a></div>      </div>

Notice of Annual General Meeting in WindowMaster International A/S 

Faron Pharmaceuticals

Herantis Pharma

Mendus

Probabilities of success in drug development

Financial Key Ratios: EV/EBIT, EV/EBITA, EV/EBITDA, and EV/Sales

Return on capital (ROE, ROI, ROIC, RONIC)

Nordea Bank

Aktionær i Nordea? Det er nemmere end nogensinde at deltage i Nordeas generalforsamling takket være nyt digitalt setup

Balance sheet, debt leverage and risks